Search

Your search keyword '"Cunningham, Philip"' showing total 665 results
Start Over Author "Cunningham, Philip"
665 results on '"Cunningham, Philip"'

1. Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot

Author

Carrington, Nigel, Conway, Anna, Grebely, Jason, Starr, Mitchell, Catlett, Beth, Stevens, Annabelle, Prain, Bianca, McGrath, Colette, Causer, Louise, Guy, Rebecca, Holden, Joanne, Keen, Phillip, Kingsland, Melanie, Lu, Heng, Power, Cherie, Read, Phillip, Murray, Carolyn, McNulty, Anna, and Cunningham, Philip

Published
2024
Full Text
View/download PDF

4. Low HIV drug resistance prevalence among recently diagnosed HIV‐positive men who have sex with men in a setting of high PrEP use

Author

King, Jonathan M., Di Giallonardo, Francesca, Shaik, Ansari, Mcgregor, Skye, Yeung, Julie Yuek Kee, Sivaruban, Tharshini, Lee, Frederick J., Cunningham, Philip, Dwyer, Dominic E., Nigro, Steven J., Grulich, Andrew E., and Kelleher, Anthony D.

Subjects
HIV (Viruses) -- Drug therapy, Genomics, Drug resistance -- Drug therapy, Highly active antiretroviral therapy, Emtricitabine, DNA polymerases, Health
Abstract

: Introduction: New South Wales (NSW) has one of the world's highest uptake rates of HIV pre‐exposure prophylaxis (PrEP). This uptake has been credited with sharp declines in HIV transmission, particularly among Australian‐born gay and bisexual men. Concerns have been raised around the potential for the emergence of tenofovir (TFV) and XTC (lamivudine/emtricitabine) resistance in settings of high PrEP use. Such an emergence could also increase treatment failure and associated clinical outcomes among people living with HIV (PLHIV). Despite low levels of nucleoside reverse‐transcriptase inhibitor (NRTI) resistance relating to PrEP use in clinical settings, there are few published studies describing the prevalence of NRTI resistance among people newly diagnosed with HIV in a setting of high PrEP use. Methods: Using HIV antiretroviral drug resistance data linked to NSW HIV notifications records of people diagnosed from 1 January 2015 to 31 December 2021 and with HIV attributed to male‐to‐male sex, we described trends in TFV and XTC resistance. Resistance was identified using the Stanford HIV Drug Resistance genotypic resistance interpretation system. To focus on transmitted drug resistance, resistance prevalence estimates were generated using sequences taken less than 3 months post‐HIV diagnosis. These estimates were stratified by timing of sequencing relative to the date of diagnosis, year of sequencing, birthplace, likely place of HIV acquisition, and stage of HIV at diagnosis. Results: Among 1119 diagnoses linked to HIV genomes sequenced less than 3 months following diagnosis, overall XTC resistance prevalence was 1.3%. Between 2015 and 2021, XTC resistance fluctuated between 0.5% to 2.9% and was 1.0% in 2021. No TFV resistance was found over the study period in any of the sequences analysed. Higher XTC resistance prevalence was observed among people with newly acquired HIV (evidence of HIV acquisition in the 12 months prior to diagnosis; 2.9%, p = 0.008). Conclusions: In this Australian setting, TFV and XTC resistance prevalence in new HIV diagnoses remained low. Our findings offer further evidence for the safe scale‐up of PrEP in high‐income settings, without jeopardizing the treatment of those living with HIV., INTRODUCTION Australia has made remarkable progress in its effort to meet the UNAIDS 2030 target of ending AIDS as a public health threat with HIV diagnoses attributed to male‐to‐male sex [...]

Published
2024
Full Text
View/download PDF

6. Self- versus clinician-collected swabs in anal cancer screening: A clinical trial.

Author

Dyer, Clare E. F., Jin, Fengyi, Roberts, Jennifer M., Poynten, I. Mary, Farnsworth, Annabelle, McNally, Leon P., Cunningham, Philip H., Grulich, Andrew E., and Hillman, Richard J.

Subjects
ANAL cancer, HUMAN papillomavirus, HUMAN sexuality, SEXUAL orientation, EARLY detection of cancer
Abstract

Background: Risk of anal cancer is high in certain populations and screening involves collection of anal swabs for HPV DNA and/or cytology testing. However, barriers exist, such as the need for an intimate examination, and stigma around HIV status, sexual orientation, and sexual practices. Self-collected anal swabs (SCA) are a proposed alternative to clinician-collected swabs (CCA) to overcome these barriers. Methods: Participants were order-randomised to undergo SCA or CCA first, with a second swab taken immediately afterwards. Sample adequacy was assessed for HPV DNA and cytology testing. CCA was used as the gold standard to calculate sensitivity and specificity of SCA for cytology and HPV results. Acceptability of swab collection was assessed following the procedure. Results: There was no significant difference in sample validity for HPV DNA testing between SCA and CCA (p = 0.564). Concordance was >90% for detection of any HR-HPV and HPV16. There was no significant difference in cellular adequacy for cytological testing between SCA and CCA, (p = 0.162). Concordance for cytologic prediction was 88.2% for any cytologic abnormality. Almost half (48.5%) of participants expressed no preference for SCA versus CCA; 15.2% preferred SCA and 35.4% CCA. Conclusions: SCA may be an acceptable and feasible alternative to CCA for detecting HPV and cytological abnormalities in a clinic population. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

7. Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote Australia.

Author

Applegate, Tanya L., Causer, Louise M., Gow, Ineka, Alternetti, Nina, Anderson, Lorraine, Borgnolo, Bianca, Cooney, Lauren, Cunningham, Philip, Fernando, Melanie, Hengel, Belinda, Huang, Rae-Lin, Kayago, Kyana, King, Jonathan M., Lew, Hau Joe, Martinello, Marianne, Milic, Melisa, Miller, Kelcie, O'Connor, Sean, Patel, Prital, and Phillips, Emily

Abstract

Introduction: Decentralized molecular testing for infectious disease diagnosis at the point-of-care (POC) is critical to address inequities in access to timely, informed health care. The COVID-19 pandemic accelerated the demand, development and adoption of POC tests for infectious diseases globally. This has provided opportunities to maximize the individual benefits and public health impact of POC testing, particularly in remote and resource-limited primary care settings. Despite this, there remains a lack of harmonized, regulatory compliance and quality management frameworks for the delivery of molecular POC testing networks outside the laboratory setting. Areas Covered: This Perspective describes real-world lessons and experiences of delivering a fit-for-purpose, quality framework for one of the world's largest decentralized molecular POC testing programs for infectious disease across rural and remote Australian communities. Here we detail unique, key considerations to ensure the quality of POC testing in primary health settings with global application. Expert Opinion: There is an ethical and public health imperative to provide sustained access to decentralized POC testing for infectious disease in primary care. Genuine partnerships across stakeholders and disciplines are essential to deliver well governed, fit-for-purpose quality management POC testing frameworks and increase equitable access to timely, high-quality person-centered care. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey

Author

Abimiku, Alash'le G, Agwale, Simon, Archibald, Chris, Avidor, Boaz, Barbás, María Gabriela, Barre-Sinoussi, Francoise, Barugahare, Banson, Belabbes, El Hadj, Bertagnolio, Silvia, Birx, Deborah, Bobkov, Aleksei F, Brandful, James, Bredell, Helba, Brennan, Catherine A, Brooks, James, Bruckova, Marie, Buonaguro, Luigi, Buonaguro, Franco, Buttò, Stefano, Buvé, Anne, Campbell, Mary, Carr, Jean, Carrera, Alex, Carrillo, Manuel Gómez, Celum, Connie, Chaplin, Beth, Charles, Macarthur, Chatzidimitriou, Dimitrios, Chen, Zhiwei, Chijiwa, Katsumi, Cooper, David, Cunningham, Philip, Dagnra, Anoumou, de Gascun, Cillian F, Del Amo, Julia, Delgado, Elena, Dietrich, Ursula, Dwyer, Dominic, Ellenberger, Dennis, Ensoli, Barbara, Essex, Max, Gao, Feng, Fleury, Hervé, Fonjungo, Peter N, Foulongne, Vincent, Gadkari, Deepak A, García, Federico, Garsia, Roger, Gershy-Damet, Guy Michel, Glynn, Judith R, Goodall, Ruth, Grossman, Zehava, Lindenmeyer-Guimarães, Monick, Hahn, Beatrice, Hamers, Raph L, Hamouda, Osamah, Handema, Ray, He, Xiang, Herbeck, Joshua, Ho, David D, Holguin, Africa, Hosseinipour, Mina, Hunt, Gillian, Ito, Masahiko, Bel Hadj Kacem, Mohamed Ali, Kahle, Erin, Kaleebu, Pontiano, Kalish, Marcia, Kamarulzaman, Adeeba, Kang, Chun, Kanki, Phyllis, Karamov, Edward, Karasi, Jean-Claude, Kayitenkore, Kayitesi, Kelleher, Tony, Kitayaporn, Dwip, Kostrikis, Leondios G, Kucherer, Claudia, Lara, Claudia, Leitner, Thomas, Liitsola, Kirsi, Lingappa, Jai, Linka, Marek, Lorenzana de Rivera, Ivette, Lukashov, Vladimir, Maayan, Shlomo, Mayr, Luzia, McCutchan, Francine, Meda, Nicolas, Menu, Elisabeth, Mhalu, Fred, Mloka, Doreen, Mokili, John L, Montes, Brigitte, Mor, Orna, Morgado, Mariza, Mosha, Fausta, Moussi, Awatef, Mullins, James, Najera, Rafael, Nasr, Mejda, Ndembi, Nicaise, Neilson, Joel R, Nerurkar, Vivek R, Neuhann, Florian, Nolte, Claudine, Novitsky, Vlad, Nyambi, Philippe, Ofner, Marianna, Paladin, Fem J, Papa, Anna, Pape, Jean, Parkin, Neil, Parry, Chris, Peeters, Martine, Pelletier, Alexandra, Pérez-Álvarez, Lucía, Pillay, Deenan, Pinto, Angie, Quang, Trinh Duy, Rademeyer, Cecilia, Raikanikoda, Filimone, Rayfield, Mark A, Reynes, Jean-Marc, Rinke de Wit, Tobias, Robbins, Kenneth E, Rolland, Morgane, Rousseau, Christine, Salazar-Gonzales, Jesus, Salem, Hanan, Salminen, Mika, Salomon, Horacio, Sandstrom, Paul, Santiago, Mario L, Sarr, Abdoulaye D, Schroeder, Bryan, Segondy, Michel, Selhorst, Philippe, Sempala, Sylvester, Servais, Jean, Shaik, Ansari, Shao, Yiming, Slim, Amine, Soares, Marcelo A, Songok, Elijah, Stewart, Debbie, Stokes, Julie, Subbarao, Shambavi, Sutthent, Ruengpung, Takehisa, Jun, Tanuri, Amilcar, Tee, Kok Keng, Thapa, Kiran, Thomson, Michael, Tran, Tyna, Urassa, Willy, Ushijima, Hiroshi, van de Perre, Philippe, van der Groen, Guido, van Laethem, Kristel, van Oosterhout, Joep, van Sighem, Ard, van Wijngaerden, Eric, Vandamme, Anne-Mieke, Vercauteren, Jurgen, Vidal, Nicole, Wallace, Lesley, Williamson, Carolyn, Wolday, Dawit, Xu, Jianqing, Yang, Chunfu, Zhang, Linqi, Zhang, Rong, Hemelaar, Joris, Elangovan, Ramyiadarsini, Yun, Jason, Dickson-Tetteh, Leslie, Kirtley, Shona, Gouws-Williams, Eleanor, and Ghys, Peter D

Published
2020
Full Text
View/download PDF

11. Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype

Author

Zaunders, John, Dyer, Wayne B., Churchill, Melissa, Munier, C Mee Ling, Cunningham, Philip H., Suzuki, Kazuo, McBride, Kristin, Hey-Nguyen, Will, Koelsch, Kersten, Wang, Bin, Hiener, Bonnie, Palmer, Sarah, Gorry, Paul R., Bailey, Michelle, Xu, Yin, Danta, Mark, Seddiki, Nabila, Cooper, David A., Saksena, Nitin K., Sullivan, John S., Riminton, Sean, Learmont, Jenny, and Kelleher, Anthony D.

Published
2019
Full Text
View/download PDF

12. Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

Author

Abimiku, Alash'le G, Agwale, Simon, Archibald, Chris, Avidor, Boaz, Barbás, María Gabriela, Barre-Sinoussi, Francoise, Barugahare, Banson, Belabbes, El Hadj, Bertagnolio, Silvia, Birx, Deborah, Bobkov, Aleksei F, Brandful, James, Bredell, Helba, Brennan, Catherine A, Brooks, James, Bruckova, Marie, Buonaguro, Luigi, Buonaguro, Franco, Buttò, Stefano, Buve, Anne, Campbell, Mary, Carr, Jean, Carrera, Alex, Carrillo, Manuel Gómez, Celum, Connie, Chaplin, Beth, Charles, Macarthur, Chatzidimitriou, Dimitrios, Chen, Zhiwei, Chijiwa, Katsumi, Cooper, David, Cunningham, Philip, Dagnra, Anoumou, de Gascun, Cillian F, Del Amo, Julia, Delgado, Elena, Dietrich, Ursula, Dwyer, Dominic, Ellenberger, Dennis, Ensoli, Barbara, Essex, Max, Gao, Feng, Fleury, Herve, Fonjungo, Peter N, Foulongne, Vincent, Gadkari, Deepak A, García, Federico, Garsia, Roger, Gershy-Damet, Guy Michel, Glynn, Judith R, Goodall, Ruth, Grossman, Zehava, Lindenmeyer-Guimarães, Monick, Hahn, Beatrice, Hamers, Raph L, Hamouda, Osamah, Handema, Ray, He, Xiang, Herbeck, Joshua, Ho, David D, Holguin, Africa, Hosseinipour, Mina, Hunt, Gillian, Ito, Masahiko, Bel Hadj Kacem, Mohamed Ali, Kahle, Erin, Kaleebu, Pontiano Kaleebu, Kalish, Marcia, Kamarulzaman, Adeeba, Kang, Chun, Kanki, Phyllis, Karamov, Edward, Karasi, Jean-Claude, Kayitenkore, Kayitesi, Kelleher, Tony, Kitayaporn, Dwip, Kostrikis, Leondios G, Kucherer, Claudia, Lara, Claudia, Leitner, Thomas, Liitsola, Kirsi, Lingappa, Jai, Linka, Marek, Lorenzana de Rivera, Ivette, Lukashov, Vladimir, Maayan, Shlomo, Mayr, Luzia, McCutchan, Francine, Meda, Nicolas, Menu, Elisabeth, Mhalu, Fred, Mloka, Doreen, Mokili, John L, Montes, Brigitte, Mor, Orna, Morgado, Mariza, Mosha, Fausta, Moussi, Awatef, Mullins, James, Najera, Rafael, Nasr, Mejda, Ndembi, Nicaise, Neilson, Joel R, Nerurkar, Vivek R, Neuhann, Florian, Nolte, Claudine, Novitsky, Vlad, Nyambi, Philippe, Ofner, Marianna, Paladin, Fem J, Papa, Anna, Pape, Jean, Parkin, Neil, Parry, Chris, Peeters, Martine, Pelletier, Alexandra, Pérez-Álvarez, Lucía, Pillay, Deenan, Pinto, Angie, Quang, Trinh Duy, Rademeyer, Cecilia, Raikanikoda, Filimone, Rayfield, Mark A, Reynes, Jean-Marc, Rinke de Wit, Tobias, Robbins, Kenneth E, Rolland, Morgane, Rousseau, Christine, Salazar-Gonzales, Jesus, Salem, Hanan, Salminen, Mika, Salomon, Horacio, Sandstrom, Paul, Santiago, Mario L, Sarr, Abdoulaye D, Schroeder, Bryan, Segondy, Michel, Selhorst, Philippe, Sempala, Sylvester, Servais, Jean, Shaik, Ansari, Shao, Yiming, Slim, Amine, Soares, Marcelo A, Songok, Elijah, Stewart, Debbie, Stokes, Julie, Subbarao, Shambavi, Sutthent, Ruengpung, Takehisa, Jun, Tanuri, Amilcar, Tee, Kok Keng, Thapa, Kiran, Thomson, Michael, Tran, Tyna, Urassa, Willy, Ushijima, Hiroshi, van de Perre, Philippe, van der Groen, Guido, van Laethem, Kristel, van Oosterhout, Joep, van Sighem, Ard, van Wijngaerden, Eric, Vandamme, Anne-Mieke, Vercauteren, Jurgen, Vidal, Nicole, Wallace, Lesley, Williamson, Carolyn, Wolday, Dawit, Xu, Jianqing, Yang, Chunfu, Zhang, Linqi, Zhang, Rong, Hemelaar, Joris, Elangovan, Ramyiadarsini, Yun, Jason, Dickson-Tetteh, Leslie, Fleminger, Isabella, Kirtley, Shona, Williams, Brian, Gouws-Williams, Eleanor, and Ghys, Peter D

Published
2019
Full Text
View/download PDF

15. HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity

Author

Suzuki, Kazuo, Levert, Angelique, Yeung, Julie, Starr, Mitchell, Cameron, Jane, Williams, Raffaella, Rismanto, Nikolas, Stark, Tayla, Druery, Dylan, Prasad, Salzeena, Ferrarini, Cristina, Hanafi, Imelda, McNally, Leon Patrick, Cunningham, Philip, Liu, Zhixin, Ishida, Takaomi, Huang, Chin-Shiou, Oswald, Velma, Evans, Louise, Symonds, Geoffrey, Brew, Bruce James, and Zaunders, John

Published
2021
Full Text
View/download PDF

16. Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay

Author

LiveRLife Study Group, Lamoury, Francois M. J., Bajis, Sahar, Hajarizadeh, Behzad, Marshall, Alison D., Martinello, Marianne, Ivanova, Elena, Catlett, Beth, Mowat, Yasmin, Marks, Philippa, Amin, Janaki, Smith, Julie, Ezard, Nadine, Cock, Victoria, Hayllar, Jeremy, Persing, David H., Kleman, Marika, Cunningham, Philip, Dore, Gregory J., Applegate, Tanya L., and Grebely, Jason

Published
2018

18. Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study

Author

Conway, Anna, primary, Stevens, Annabelle, additional, Murray, Carolyn, additional, Prain, Bianca, additional, Power, Cherie, additional, McNulty, Anna, additional, Carrington, Nigel, additional, Lu, Heng, additional, Kingsland, Melanie, additional, McGrath, Colette, additional, Read, Phillip, additional, Starr, Mitchell, additional, Catlett, Beth, additional, Cunningham, Philip, additional, and Grebely, Jason, additional

Published
2023
Full Text
View/download PDF

22. Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study

Author

Grebely, Jason, Lamoury, Francois M J, Hajarizadeh, Behzad, Mowat, Yasmin, Marshall, Alison D, Bajis, Sahar, Marks, Philippa, Amin, Janaki, Smith, Julie, Edwards, Michael, Gorton, Carla, Ezard, Nadine, Persing, David, Kleman, Marika, Cunningham, Philip, Catlett, Beth, Dore, Gregory J, and Applegate, Tanya L

Published
2017
Full Text
View/download PDF

26. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants

Author

Tea, Fiona, Ospina Stella, Alberto, Aggarwal, Anupriya, Ross Darley, David, Pilli, Deepti, Vitale, Daniele, Merheb, Vera, Lee, Fiona X. Z., Cunningham, Philip, Walker, Gregory J., Fichter, Christina, Brown, David A., Rawlinson, William D., Isaacs, Sonia R., Mathivanan, Vennila, Hoffmann, Markus, Pöhlman, Stefan, Mazigi, Ohan, Christ, Daniel, Dwyer, Dominic E., Rockett, Rebecca J., Sintchenko, Vitali, Hoad, Veronica C., Irving, David O., Dore, Gregory J., Gosbell, Iain B., Kelleher, Anthony D., Matthews, Gail V., Brilot, Fabienne, and Turville, Stuart G.

Subjects
Diseases -- Relapse, Viral antibodies -- Health aspects, Immune response -- Health aspects, Antibodies -- Health aspects, Biological sciences
Abstract

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization response and its evasion by emerging viral variants and variant of concern (VOC) are unknown, but critical to understand reinfection risk and breakthrough infection following vaccination. Antibody immunoreactivity against SARS-CoV-2 antigens and Spike variants, inhibition of Spike-driven virus-cell fusion, and infectious SARS-CoV-2 neutralization were characterized in 807 serial samples from 233 reverse transcription polymerase chain reaction (RT-PCR)-confirmed Coronavirus Disease 2019 (COVID-19) individuals with detailed demographics and followed up to 7 months. A broad and sustained polyantigenic immunoreactivity against SARS-CoV-2 Spike, Membrane, and Nucleocapsid proteins, along with high viral neutralization, was associated with COVID-19 severity. A subgroup of 'high responders' maintained high neutralizing responses over time, representing ideal convalescent plasma donors. Antibodies generated against SARS-CoV-2 during the first COVID-19 wave had reduced immunoreactivity and neutralization potency to emerging Spike variants and VOC. Accurate monitoring of SARS-CoV-2 antibody responses would be essential for selection of optimal responders and vaccine monitoring and design., Author(s): Fiona Tea 1, Alberto Ospina Stella 2, Anupriya Aggarwal 2, David Ross Darley 3,4, Deepti Pilli 1, Daniele Vitale 5, Vera Merheb 1, Fiona X. Z. Lee 1, Philip [...]

Published
2021
Full Text
View/download PDF

27. Artemis, Tiangong successes in space race leave Russia in dust

Author

Cunningham, Philip J.

Subjects
Space stations, Outer space -- Discovery and exploration, News, opinion and commentary
Abstract

Space exploration, once a spirited rivalry between the United States and the Soviet Union, has now become a contest between the US and China. Recent weeks have seen advances in [...]

Published
2022

30. High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells

Author

Phetsouphanh, Chansavath, primary, Khoo, Weng Hua, additional, Jackson, Katherine, additional, Klemm, Vera, additional, Howe, Annett, additional, Aggarwal, Anupriya, additional, Akerman, Anouschka, additional, Milogiannakis, Vanessa, additional, Stella, Alberto Ospina, additional, Rouet, Romain, additional, Schofield, Peter, additional, Faulks, Megan L., additional, Law, Hannah, additional, Danwilai, Thidarat, additional, Starr, Mitchell, additional, Munier, C. Mee Ling, additional, Christ, Daniel, additional, Singh, Mandeep, additional, Croucher, Peter I., additional, Brilot-Turville, Fabienne, additional, Turville, Stuart, additional, Phan, Tri Giang, additional, Dore, Gregory J., additional, Darley, David, additional, Cunningham, Philip, additional, Matthews, Gail V., additional, Kelleher, Anthony D., additional, and Zaunders, John J., additional

Published
2022
Full Text
View/download PDF

31. A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia

Author

Hosseini-Hooshyar, Samira, Sheehan, Yumi, Shaw, Ineke, Cunningham, Philip, Fowlie, Carrie, Marshall, Alison D, Byrne, Marianne, Treloar, Carla, Shih, Sophy TF, Gray, Richard T, Wiseman, Virginia, Applegate, Tanya L, Guy, Rebecca, Martinello, Marianne, Hajarizadeh, Behzad, Lafferty, Lise, Dimech, Wayne, Cabuang, Liza, Dawson, Olivia, Read, Philip, Pedrana, Alisa, Thompson, Alexander J, O'Loan, Joss, Grebely, Jason, Markus, Corey, Causer, Louise M, Silk, David, Comben, Simon, Lloyd, Andrew R, Martinez, Maria, Cunningham, Evan B, O'Flynn, Mim, Dore, Gregory J, and Matthews, Susan

Published
2023
Full Text
View/download PDF

35. A bipolar world is re-emerging, as China and Russia join hands

Author

Cunningham, Philip J.

Subjects
News, opinion and commentary
Abstract

Beijing and Moscow have good reason to feel isolated and unloved these days, and in their loneliness they have found each other. The two erstwhile fraternal communist giants are closer [...]

Published
2022

38. A national survey integrating clinical, laboratory, and WASH data to determine the typology of trachoma in Nauru

Author

Lynch, Kathleen D., primary, Apadinuwe, Sue Chen, additional, Lambert, Stephen B., additional, Hillgrove, Tessa, additional, Starr, Mitchell, additional, Catlett, Beth, additional, Ware, Robert S., additional, Cama, Anasaini, additional, Webster, Sara, additional, Harding-Esch, Emma M., additional, Bakhtiari, Ana, additional, Butcher, Robert, additional, Cunningham, Philip, additional, Martin, Diana, additional, Gwyn, Sarah, additional, Solomon, Anthony W., additional, Garabwan, Chandalene, additional, Kaldor, John M., additional, and Vaz Nery, Susana, additional

Published
2022
Full Text
View/download PDF

39. Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review

Author

Catlett, Beth, primary, Hajarizadeh, Behzad, additional, Cunningham, Evan, additional, Wolfson-Stofko, Brett, additional, Wheeler, Alice, additional, Khandaker-Hussain, Benazir, additional, Feld, Jordan J, additional, Martró, Elisa, additional, Chevaliez, Stéphane, additional, Pawlotsky, Jean Michel, additional, Bharat, Chrianna, additional, Cunningham, Philip H, additional, Dore, Gregory J, additional, Applegate, Tanya, additional, and Grebely, Jason, additional

Published
2022
Full Text
View/download PDF

41. New Stories for a New Relationship.

Author

Cunningham, Philip

Abstract

Discusses some of the modern events that have mandated a reconceptualization of the traditional relationship between Christianity and Judaism. These include an understanding and awareness of past stereotypical representations, the birth of the modern state of Israel, and knowledge of the end result of intolerance as represented by the Holocaust. (MJP)

Published
1996

47. Is the pope 'anti-Jewish'? No, but here's why his critics think so

Author

Cunningham, Philip A.

Subjects
Christian-Jewish relations -- Evaluation, Biblical hermeneutics -- Evaluation, Antisemitism -- Analysis, Humanities, Literature/writing, Political science
Abstract

Although great progress has been made in the past fifty years in Catholic-Jewish relations, there remains an underlying fragility. Not surprisingly, reflexes that developed over centuries of estrangement do not [...]

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results